These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4357775)

  • 1. [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice].
    Moulias R; Goust JM; Reinert P; Fournel JJ; Deville-Chabrolle A; Duoung N; Muller-Berat CN; Berthaux P
    Nouv Presse Med; 1973 May; 2(20):1341-4. PubMed ID: 4357775
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice].
    Moulias R; Goust JM; Reinert P; Fournel JJ; Deville-Chabrolle A; Duong N; Muller-Berat CN; Berthaux P
    Nouv Presse Med; 1973 May; 2(20):1341-4. PubMed ID: 4351886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific immunotherapy using cell-mediated immune transfer factor. Preliminary results with semi-purified transfer factor].
    Berthaux P; Moulias R; Goust JM; Reinert P; Fournel JJ
    Ann Med Interne (Paris); 1972 Dec; 123(12):1069-72. PubMed ID: 4664543
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer factor therapy in immuno-deficiencies.
    Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological defence and transfer factor therapy in chronic mucocutaneous candidiasis].
    Bläker F; Grob PJ; Hellwege HH; Schulz KH
    Dtsch Med Wochenschr; 1973 Mar; 98(9):415-20. PubMed ID: 4691560
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic uses of transfer factor.
    Hitzig WH; Grob PJ
    Prog Clin Immunol; 1974; 2():69-100. PubMed ID: 4217910
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in subacute sclerosing panencephalitis.
    Valdimarsson H; Agnarsdottir G; Lachmann PJ
    Proc R Soc Med; 1974 Nov; 67(11):1125-9. PubMed ID: 4548192
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic mucocutaneous moniliasis. Immunological clinical study of a case and trial treatment with the transfer factor].
    Touraine JL; Freycon F; Kraft O; Betuel H; Freycon MT; Larbre F
    Pediatrie; 1973; 28(3):271-81. PubMed ID: 4726384
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
    Valdimarsson H; Wood CB; Hobbs JR; Holt PJ
    Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular immunity and measles virus in Van Bogaert's subacute sclerosing panencephalitis. Apropos of a case].
    Bizouard P; Hervé P; Lonchamp D; Estavoyer JM; Lamit J; Raffi A
    Pediatrie; 1973; 28(7):703-11. PubMed ID: 4803532
    [No Abstract]   [Full Text] [Related]  

  • 15. [Demonstration of cellular immunity deficiency limited to measles virus in 20 cases of subacute sclerosing leukoencephalitis].
    Reinert P; Moulias R; Goust JM; Hors J; Bussel A
    Arch Fr Pediatr; 1972; 29(6):655-65. PubMed ID: 5078364
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer factor in diseases of the central nervous system.
    Graybill JR
    Adv Neurol; 1974; 6():107-26. PubMed ID: 4614652
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempt of transfer-factor therapy of subacute sclerosing panencephalitis].
    Schumacher H
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):429-30. PubMed ID: 4408624
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfer factor as an approach to the treatment of immune deficiency disease.
    Schulkind ML; Ayoub EM
    Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 20. Phytohemagglutinin as a skin test for the evaluation of cellular immune competence in man.
    Blaese RM; Weiden P; Oppenheim JJ; Waldmann TA
    J Lab Clin Med; 1973 Apr; 81(4):538-48. PubMed ID: 4696186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.